|By PR Newswire||
|March 25, 2014 10:10 AM EDT||
WARREN, N.J., March 25, 2014 /PRNewswire/ -- Roka Bioscience announced today that its Atlas Listeria monocytogenes LmG2 Detection Assay ("Atlas LmG2 assay") has received AOAC Performance Tested MethodsSM certification from the AOAC Research Institute (AOAC-RI). The independent laboratory study testing was conducted by Silliker, Inc., as part of the AOAC-RI independent third-party evaluation and validation processes.
The Atlas LmG2 assay is approved for the detection of Listeria monocytogenes from 25 g food samples and an environmental surface after a 24 hour enrichment. Additionally, the assay is approved for 125 g food samples utilizing a single, 44 hour enrichment step.
Combining our Atlas LmG2 assay with our existing Listeria spp. assay completes Roka's Listeria testing solution and augments our product portfolio that now includes Listeria spp., Salmonella, E. coli O157:H7 and STEC.
Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit www.rokabio.com.
The AOAC Research Institute (AOAC-RI) is a wholly owned subsidiary of AOAC INTERNATIONAL (AOAC) that administers AOAC's conformity assessment, including the AOAC Performance Tested MethodsSM program. AOAC is a globally recognized, independent, not-for-profit standards developing association founded in 1884. AOAC serves the analytical community by engaging industry stakeholders to develop voluntary consensus standards for methods and providing analytical methods that demonstrate confidence in analytical results. For more information on the AOAC-RI and AOAC, visit the AOAC website at www.aoac.org.
Chief Financial Officer (908) 605-4621
SOURCE Roka Bioscience
Jul. 3, 2015 06:30 PM EDT Reads: 1,200
Jul. 3, 2015 05:30 PM EDT Reads: 462
Jul. 3, 2015 05:30 PM EDT Reads: 432
Jul. 3, 2015 05:00 PM EDT Reads: 902
Jul. 3, 2015 04:45 PM EDT Reads: 824
Jul. 3, 2015 04:15 PM EDT Reads: 597
Jul. 3, 2015 04:15 PM EDT Reads: 405
Jul. 3, 2015 02:45 PM EDT Reads: 813
Jul. 3, 2015 02:45 PM EDT Reads: 908
Jul. 3, 2015 02:00 PM EDT Reads: 2,177
Jul. 3, 2015 02:00 PM EDT Reads: 2,132
Jul. 3, 2015 01:45 PM EDT Reads: 554
Jul. 3, 2015 01:30 PM EDT Reads: 1,161
Jul. 3, 2015 12:30 PM EDT Reads: 1,389
"We provide a web application framework for building really sophisticated web applications that run on a browser without any installation need so we get used for biotech, defense, and banking applications," noted Charles Kendrick, CTO and Chief Architect at Isomorphic Software, in this SYS-CON.tv interview at @DevOpsSummit (http://DevOpsSummit.SYS-CON.com), held June 9-11, 2015, at the Javits Center in New York
Jul. 3, 2015 12:30 PM EDT Reads: 1,279